InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
76,898.90
(
0.43%
)
Post# of 253566
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: DewDiligence post# 50569

Saturday, 08/04/2007 10:52:39 AM

Saturday, August 04, 2007 10:52:39 AM

Post# of 253566
Dew--What is your take on AMGN's acquisitions of Alantos and Ilypsa? AMGN has done alot of deals. Do you think that these deals can offset $'s lost when its drugs go off patent?

FWIW-I'm postive on the anti-RANKL program, and think that successful development of this drug could help AMGN to maintain its revenue.

biophud
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up